GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $875,029 | +26.0% | 340,478 | 0.0% | 0.00% | – |
| Q4 2023 | $694,576 | +18.3% | 340,478 | -0.3% | 0.00% | – |
| Q3 2023 | $587,292 | -11.8% | 341,449 | 0.0% | 0.00% | – |
| Q2 2023 | $665,825 | -80.8% | 341,449 | -55.1% | 0.00% | -100.0% |
| Q1 2022 | $3,470,000 | -69.4% | 760,986 | -22.3% | 0.00% | -66.7% |
| Q4 2021 | $11,341,000 | +31.4% | 979,343 | +30.5% | 0.00% | 0.0% |
| Q3 2021 | $8,631,000 | +134.7% | 750,529 | +86.3% | 0.00% | +200.0% |
| Q2 2021 | $3,678,000 | +192.1% | 402,796 | +201.7% | 0.00% | – |
| Q1 2021 | $1,259,000 | +103.1% | 133,526 | -15.2% | 0.00% | – |
| Q4 2020 | $620,000 | +46.6% | 157,370 | -1.4% | 0.00% | – |
| Q3 2020 | $423,000 | -53.8% | 159,610 | +15.6% | 0.00% | – |
| Q2 2020 | $916,000 | +25.3% | 138,015 | +9.9% | 0.00% | – |
| Q1 2020 | $731,000 | -30.1% | 125,568 | +7.8% | 0.00% | – |
| Q4 2019 | $1,046,000 | +3.1% | 116,529 | -0.9% | 0.00% | – |
| Q3 2019 | $1,015,000 | +36.2% | 117,584 | +75.8% | 0.00% | – |
| Q2 2019 | $745,000 | – | 66,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
| FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
| EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
| Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
| Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
| BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
| Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
| ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
| DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
| HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |